株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のアブレーション技術市場:市場動向・競合分析(2011年〜2016年)

Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis

発行 MarketsandMarkets 商品コード 240032
出版日 ページ情報 英文 350 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
世界のアブレーション技術市場:市場動向・競合分析(2011年〜2016年) Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis
出版日: 2012年05月09日 ページ情報: 英文 350 Pages
概要

世界のアブレーション技術市場額は、2011年に75億米ドルとなりました。同市場は今後、CAGR10.5%で成長し、2016年までに124億米ドルに達すると予測されています。

当レポートでは、世界のアブレーション技術市場について、アプリケーションおよび製品別に調査分析しており、地域別の分析、競合情勢の分析、主要企業のプロファイルになどについてまとめ、概略下記の構成でお届けいたします。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • アブレーション技術市場
  • アブレーションのアプリケーション市場
  • 市場力学
  • ビジネス課題
  • 市場シェア分析

第4章 アブレーション市場:技術別

  • イントロダクション
  • 熱以外

第5章 アブレーション技術市場:製品別

  • 電気
  • 放射線
  • 高周波
  • 光/レーザー
  • 超音波
  • マイクロ波
  • 熱水
  • 冷凍

第6章 アブレーション技術市場:アプリケーション別

  • イントロダクション
  • 心臓血管
  • 眼科
  • 婦人科
  • 泌尿器科
  • 整形外科
  • その他

第7章 地域別分析

  • イントロダクション
  • 南北アメリカ
  • 欧州
  • アジア太平洋地域
  • その他

第8章 競合情勢

  • イントロダクション
  • M&A
  • 合意、提携、協力、ジョイントベンチャー
  • 新製品開発
  • パイプライン開発
  • その他の開発

第9章 企業プロファイル

図表

目次
Product Code: BT 1155

Abstract

Report Description

Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis

The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics. Global ablation technologies market was valued at $7.5 billion in 2011 and is poised to grow at a CAGR of 10.5% to reach $12.4 billion by 2016.

A significant growth has been seen in the procedures of ablation in the recent years, which is largely driven by healthcare, demographic, and cost-effective factors. Increasing application in clinical areas such cancer and cardiac together, have contribute to this growth in ablation procedures.

The major driving factor for these markets would be the technological advancements and increasing demand for minimally invasive surgical procedures. In addition, Older population is growing in the mature markets such as Japan, U.S. and in the Western European countries. With increasing age, the risk of developing chronic diseases such as cancer, cardiovascular disorders, gynaecological, and orthopaedic problems increases. As the incidence cases of these chronic diseases continue to rise in the coming years, the ablation devices market for treating these diseases would show significant growth in the forecast period. The principal advantage of ablation procedures over surgery is short recovery time, short length scars, low risk of infection, minimal damage to the healthy tissue, less blood loss, and shorter hospital stays.

In 2011, radiation therapy contributed to over 41% of the total ablation technologies market. The major driver of radiation therapy is the fact that it is applicable to any form of cancer ranging from soft tissue such as liver, lungs to bone metastases. Unlike most other techniques, radiation therapy is considered to be effective in all cancer scenarios, thus it is a single treatment for control of cancer used by most radiologists. It is expected that, radiation therapy will continue to enjoy the majority share in the ablation technologies market for at least another decade owing to its broad scope of use, different methods of application, stable acceptance in population, and high level of awareness as compared to newly introduced ablation techniques such as hydrothermal, microwave and hydromechanical ablation.

Americas is the biggest market for ablation devices, followed by Europe. However, Asian countries represent the fastest growing markets and factors such as high patient pool, growing preferences to minimally invasive surgery, geographical expansion of market players, increased government investment in healthcare facilities especially in rural areas, westernization in life style and dietary habits, increasing healthcare expenditure & improving medical insurance plans, are driving the ablation devices market.

Ablation technologies market research report categorizes the global market on the basis of application, devices and market trends; competitive analysis. Report also includes company profiles of major players such as Accuray (U.S.), Alcon Laboratories Inc. (U.S.), AngioDynamics Inc. (U.S.), Arthrocare Corporation (U.S.), Atricure Inc. (U.S.), Biosense Webster (U.S.), Boston Scientific (U.S.), BSD Medical Corporation (U.S.), C.R. Bard Inc. (U.S.), Conmed Corporation (U.S.), Covidien (Ireland), Elekta AB ( Sweden), Galil Medical ltd. (Israel), Medtronic Inc. (U.S.), Misonix Inc. (U.S.), nContact Surgical Inc. (U.S.), Olympus Corporation (Japan), Smith & Nephew (U.K.), St. Jude Medical (U.S.), Urologix Inc. (U.S.) and Varian Medical Systems Inc. (U.S.).

Summary

Ablation procedure refers to a minimally invasive surgical procedure, which involves either destruction or removal of diseased or unnecessary tissue, with the aim to cure the disease. It provides successful form of surgical option that has gradually becoming a popular alternative over invasive procedure amongst physicians and patients. The principal advantage of these procedures over surgery is short recovery time, short length scars, low risk of infection, less blood loss, and shorter hospital stays.

Technological innovations in these ablation devices have been seen in the past years. Newer devices with better safety and efficacy attributes contribute to widespread adoption of the ablation procedures by physicians worldwide. Of all the ablation technologies, radiation technology is most widely used. Cancer and cardiac ablation are the major application areas and accounts for ~64% share in the ablation market. Cardiac ablation is considered as the burning issue in ablation devices industry as many market players are currently performing clinical trials on ablation devices in the cardiac segment and see a high growth opportunity in the coming future.

Rapid developments are taking place in the field of new irrigated catheters (which provide enhanced lesion formation along with more efficient cooling), force sensing catheters (for accurate determination of force applied on the tissue), multielectrode RF (to make complex lesion sets through a single application) and in radiometric temperature sensing catheter (to measure the temperature of heated tissue during ablation).

Patients and physicians are increasingly inclined towards the usage and reception of new ablation technologies due to the numerous advantages offered by these devices. In addition, industry players have identified the growth opportunities in the ablation devices market, and are in process to come up with more efficient innovations and developments in this field.

The penetration rate of minimally invasive surgical procedures and ablation techniques is faltering in the emerging markets. However, established companies and new entrants in the ablation devices market should consider these GDP growth rates, increasing procedural volumes and low penetration rates compared to mature markets, as the driving opportunistic factors that will plant the seed for future possible success for such companies.

image1

adiation accounted for major share in the thermal ablation technologies, where as cryoablation holds maximum share in non - thermal ablation technologies.

Table of Contents

1 INTRODUCTION

  • 1.1 KEY TAKE AWAYS
  • 1.2 REPORT DESCRIPTION
  • 1.3 MARKETS COVERED
  • 1.4 STAKEHOLDERS
  • 1.5 RESEARCH METHODOLOGY
    • 1.5.1 MARKET SIZE
    • 1.5.2 MARKET SHARE
    • 1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
    • 1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
    • 1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

  • 3.1 INTRODUCTION
  • 3.2 ABLATION TECHNOLOGIES MARKET
  • 3.3 ABLATION APPLICATION MARKET
  • 3.4 MARKET DYNAMICS
    • 3.4.1 DRIVERS
      • 3.4.1.1 Technological advancements
      • 3.4.1.2 Increasing procedures through minimal invasive surgery
      • 3.4.1.3 Increasing aging population with higher risk of chronic diseases
    • 3.4.2 RESTRAINTS
      • 3.4.2.1 Pricing and reimbursement issues
      • 3.4.2.2 Increasing regulatory agencies pressures
    • 3.4.3 OPPORTUNITIES & CHALLENGES
      • 3.4.3.1 Emerging markets
      • 3.4.3.2 Technical and educational challenges
  • 3.5 BURNING ISSUES
    • 3.5.1 INCREASING RESEARCH IN CARDIAC ABLATION
  • 3.6 MARKET SHARE ANALYSIS

4 ABLATION MARKET, BY TECHNOLOGY

  • 4.1 INTRODUCTION
  • 4.2 THERMAL
    • 4.2.1 ELECTRICAL
    • 4.2.2 RADIATION
    • 4.2.3 RADIOFREQUENCY
    • 4.2.4 LIGHT
    • 4.2.5 ULTRASOUND
    • 4.2.6 MICROWAVE
    • 4.2.7 HYDROTHERMAL
  • 4.3 NON-THERMAL
    • 4.3.1 CRYOTHERAPY
    • 4.3.2 HYDROMECHANICAL

5 ABLATION TECHNOLOGY MARKET, BY PRODUCTS

  • 5.1 ELECTRICAL
    • 5.1.1 ELECTRICAL ABLATORS
      • 5.1.1.1 Argon Plasma/Beam coagulators
      • 5.1.1.2 Irreversible electroporation
    • 5.1.2 ELECTRONIC BRACHYTHERAPY
  • 5.2 RADIATION
    • 5.2.1 BRACHYTHERAPY
      • 5.2.1.1 High-Dose-Rate (HDR) brachytherapy
      • 5.2.1.2 Pulsed-Dose-Rate brachytherapy
      • 5.2.1.3 Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy
    • 5.2.2 STEREOTACTIC RADIOSURGERY & STEREOTACTIC RADIOTHERAPY
    • 5.2.3 IMAGE GUIDED RADIATION THERAPY (IGRT)
    • 5.2.4 INTENSITY-MODULATED RADIATION THERAPY (IMRT)
    • 5.2.5 STEREOTACTIC BODY RADIATION THERAPY(SBRT)
    • 5.2.6 PROTON BEAM THERAPY
  • 5.3 RADIOFREQUENCY
    • 5.3.1 TEMPERATURE CONTROLLED RADIOFREQUENCY ABLATION DEVICES
    • 5.3.2 FLUID COOLED RF ABLATION
    • 5.3.3 THE ROBOTIC CATHETER MANIPULATION SYSTEM
  • 5.4 LIGHT/ LASER
    • 5.4.1 COLD LASERS
    • 5.4.2 EXCIMER LASERS
  • 5.5 ULTRASOUND
    • 5.5.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)
    • 5.5.2 MAGNETIC RESONANCE GUIDED ULTRASOUND MRGFUS
    • 5.5.3 ULTRASONIC SURGICAL SYSTEMS
    • 5.5.4 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
  • 5.6 MICROWAVE ABLATION
    • 5.6.1 MICROWAVE THERMOTHERAPY
  • 5.7 HYDROTHERMAL ABLATION
    • 5.7.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES
  • 5.8 CRYOABLATION
    • 5.8.1 TISSUE CONTACT PROBE
    • 5.8.2 TISSUE SPRAY PROBE
    • 5.8.3 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES

6 ABLATION TECHNOLOGY MARKET, BY APPLICATIONS

  • 6.1 INTRODUCTION
  • 6.2 CANCER
  • 6.3 CARDIOVASCULAR
  • 6.4 OPHTHALMOLOGY
  • 6.5 GYNECOLOGY
  • 6.6 UROLOGY
  • 6.7 ORTHOPEDICS
  • 6.8 OTHERS

7 GEOGRAPHICAL ANALYSIS

  • 7.1 INTRODUCTION
  • 7.2 AMERICAS
  • 7.3 EUROPE
  • 7.4 ASIA-PACIFIC
  • 7.5 ROW

8 COMPETITIVE LANDSCAPE

  • 8.1 INTRODUCTION
  • 8.2 MERGERS & ACQUISITIONS
  • 8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
  • 8.4 NEW PRODUCT LAUNCHES
  • 8.5 PIPELINE DEVELOPMENTS
  • 8.6 OTHER DEVELOPMENTS

9 COMPANY PROFILES

  • 9.1 ACCURAY INC.
    • 9.1.1 OVERVIEW
    • 9.1.2 FINANCIALS
    • 9.1.3 PRODUCTS & SERVICES
    • 9.1.4 STRATEGY
    • 9.1.5 DEVELOPMENTS
  • 9.2 ALCON LABORATORIES INC.
    • 9.2.1 OVERVIEW
    • 9.2.2 FINANCIALS
    • 9.2.3 PRODUCTS & SERVICES
    • 9.2.4 STRATEGY
    • 9.2.5 DEVELOPMENTS
  • 9.3 ANGIODYNAMICS INC.
    • 9.3.1 OVERVIEW
    • 9.3.2 FINANCIALS
    • 9.3.3 PRODUCTS & SERVICES
    • 9.3.4 STRATEGY
    • 9.3.5 DEVELOPMENTS
  • 9.4 ARTHROCARE CORPORATION
    • 9.4.1 OVERVIEW
    • 9.4.2 FINANCIALS
    • 9.4.3 PRODUCTS & SERVICES
    • 9.4.4 STRATEGY
    • 9.4.5 DEVELOPMENTS
  • 9.5 ATRICURE INC.
    • 9.5.1 OVERVIEW
    • 9.5.2 FINANCIALS
    • 9.5.3 PRODUCTS & SERVICES
    • 9.5.4 STRATEGY
    • 9.5.5 DEVELOPMENTS
  • 9.6 BIOSENSE WEBSTER INC.
    • 9.6.1 OVERVIEW
    • 9.6.2 PRODUCTS & SERVICES
    • 9.6.3 STRATEGY
    • 9.6.4 DEVELOPMENTS
  • 9.7 BOSTON SCIENTIFIC CORPORATION
    • 9.7.1 OVERVIEW
    • 9.7.2 FINANCIALS
    • 9.7.3 PRODUCTS & SERVICES
    • 9.7.4 STRATEGY
    • 9.7.5 DEVELOPMENTS
  • 9.8 BSD MEDICAL CORPORATION
    • 9.8.1 OVERVIEW
    • 9.8.2 FINANCIALS
    • 9.8.3 PRODUCTS & SERVICES
    • 9.8.4 STRATEGY
    • 9.8.5 DEVELOPMENTS
  • 9.9 C.R. BARD INC.
    • 9.9.1 OVERVIEW
    • 9.9.2 FINANCIALS
    • 9.9.3 PRODUCTS & SERVICES
    • 9.9.4 STRATEGY
    • 9.9.5 DEVELOPMENTS
  • 9.10 CONMED CORPORATION
    • 9.10.1 OVERVIEW
    • 9.10.2 FINANCIALS
    • 9.10.3 PRODUCTS & SERVICES
    • 9.10.4 STRATEGY
    • 9.10.5 DEVELOPMENTS
  • 9.11 COVIDIEN PLC
    • 9.11.1 OVERVIEW
    • 9.11.2 FINANCIALS
    • 9.11.3 PRODUCTS & SERVICES
    • 9.11.4 STRATEGY
    • 9.11.5 DEVELOPMENTS
  • 9.12 ELEKTA AB
    • 9.12.1 OVERVIEW
    • 9.12.2 FINANCIALS
    • 9.12.3 PRODUCTS & SERVICES
    • 9.12.4 STRATEGY
    • 9.12.5 DEVELOPMENTS
  • 9.13 GALIL MEDICAL LTD.
    • 9.13.1 OVERVIEW
    • 9.13.2 FINANCIALS
    • 9.13.3 PRODUCTS & SERVICES
    • 9.13.4 STRATEGY
    • 9.13.5 DEVELOPMENTS
  • 9.14 MEDTRONIC INC.
    • 9.14.1 OVERVIEW
    • 9.14.2 FINANCIALS
    • 9.14.3 PRODUCTS & SERVICES
    • 9.14.4 STRATEGY
    • 9.14.5 DEVELOPMENTS
  • 9.15 MISONIX INC.
    • 9.15.1 OVERVIEW
    • 9.15.2 FINANCIALS
    • 9.15.3 PRODUCTS & SERVICES
    • 9.15.4 STRATEGY
    • 9.15.5 DEVELOPMENTS
  • 9.16 NCONTACT SURGICAL INC.
    • 9.16.1 OVERVIEW
    • 9.16.2 FINANCIALS
    • 9.16.3 PRODUCTS & SERVICES
    • 9.16.4 STRATEGY
    • 9.16.5 DEVELOPMENTS
  • 9.17 OLYMPUS CORPORATION
    • 9.17.1 OVERVIEW
    • 9.17.2 FINANCIALS
    • 9.17.3 PRODUCTS & SERVICES
    • 9.17.4 STRATEGY
    • 9.17.5 DEVELOPMENTS
  • 9.18 SMITH & NEPHEW
    • 9.18.1 OVERVIEW
    • 9.18.2 FINANCIALS
    • 9.18.3 PRODUCTS & SERVICES
    • 9.18.4 STRATEGY
    • 9.18.5 DEVELOPMENTS
  • 9.19 ST. JUDE MEDICAL INC.
    • 9.19.1 OVERVIEW
    • 9.19.2 FINANCIALS
    • 9.19.3 PRODUCTS & SERVICES
    • 9.19.4 STRATEGY
    • 9.19.5 DEVELOPMENTS
  • 9.20 UROLOGIX INC.
    • 9.20.1 OVERVIEW
    • 9.20.2 FINANCIALS
    • 9.20.3 PRODUCTS & SERVICES
    • 9.20.4 STRATEGY
    • 9.20.5 DEVELOPMENTS
  • 9.21 VARIAN MEDICAL SYSTEMS INC.

LIST OF TABLES

  • TABLE 1 GLOBAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 2 ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 3 GLOBAL THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 4 THERMAL ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 5 ELECTRIC ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 6 RADIATION ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 7 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 8 LIGHT/LASER ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 9 ULTRASOUND ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 10 MICROWAVE ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 11 HYDROTHERMAL ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 12 GLOBAL NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 13 NON-THERMAL ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 14 CRYOABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 15 HYDROMECHANICAL ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 16 GLOBAL ELECTRICAL ABLATION MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
  • TABLE 17 GLOBAL ELECTRICAL ABLATORS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
  • TABLE 18 GLOBAL ELECTRICAL ABLATION MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND)
  • TABLE 19 GLOBAL ELECTRICAL ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 20 GLOBAL ELECTRICAL ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND)
  • TABLE 21 ARGON PLASMA/BEAM COAGULATION ABLATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 22 ARGON PLASMA/BEAM COAGULATION ABLATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND)
  • TABLE 23 IRREVERSIBLE ELECTROPORATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 24 IRREVERSIBLE ELECTROPORATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND)
  • TABLE 25 ELECTRONIC BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 26 ELECTRONIC BRACHYTHERAPY MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
  • TABLE 27 GLOBAL RADIATION ABLATION PRODUCTS MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
  • TABLE 28 GLOBAL RADIATION ABLATION PRODUCTS MARKET VOLUME, BY SEGMENTS, 2009 - 2016
  • TABLE 29 GLOBAL RADIATION ABLATION PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 30 GLOBAL RADIATION ABLATION PRODUCTS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
  • TABLE 31 GLOBAL BRACHYTHERAPY MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
  • TABLE 32 GLOBAL BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 33 HIGH-DOSE-RATE (HDR) BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 34 PULSED-DOSE-RATE (PDR) BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 35 PERMANENT SEED BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 36 STEREOTACTIC RADIOSURGERY (SRS) & STEREOTACTIC RADIOTHERAPY (SRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 37 STEREOTACTIC RADIOSURGERY (SRS) & STEREOTACTIC RADIOTHERAPY (SRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
  • TABLE 38 IMAGE GUIDED RADIATION THERAPY (IGRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 39 IMAGE GUIDED RADIATION THERAPY (IGRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
  • TABLE 40 INTENSITY-MODULATED RADIATION THERAPY (IMRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 41 INTENSITY-MODULATED RADIATION THERAPY (IMRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
  • TABLE 42 STEREOTACTIC BODY RADIATION THERAPY (SBRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 43 STEREOTACTIC BODY RADIATION THERAPY (SBRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
  • TABLE 44 PROTON BEAM THERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 45 PROTON BEAM THERAPY MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
  • TABLE 46 GLOBAL RADIOFREQUENCY ABLATORS MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 47 GLOBAL RADIOFREQUENCY ABLATORS MARKET VOLUME, BY SEGMENTS, 2009 - 2011 (THOUSAND)
  • TABLE 48 GLOBAL RADIOFREQUENCY ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 49 GLOBAL RADIOFREQUENCY ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND)
  • TABLE 50 TEMPERATURE CONTROLLED ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 51 TEMPERATURE CONTROLLED ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
  • TABLE 52 FLUID COOLED ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 53 FLUID COOLED ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
  • TABLE 54 CATHETER MANIPULATION SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 55 GLOBAL LIGHT/LASER ABLATORS MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 56 GLOBAL LIGHT/LASER ABLATORS MARKET VOLUME, BY SEGMENTS, 2009 - 2011 (THOUSAND)
  • TABLE 57 LIGHT/LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 58 LIGHT/LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
  • TABLE 59 COLD LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 60 COLD LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
  • TABLE 61 EXCIMER LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 62 EXCIMER LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
  • TABLE 63 GLOBAL ULTRASOUND ABLATION PRODUCTS MARKET BY REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 64 GLOBAL ULTRASOUND ABLATION PRODUCTS MARKET BY VOLUME, BY SEGMENTS, 2009 - 2011 (THOUSAND)
  • TABLE 65 ULTRASOUND ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 66 ULTRASOUND ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
  • TABLE 67 HIGH INTENSITY FOCUSED (HIFU) ULTRASOUND ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 68 HIGH INTENSITY FOCUSED (HIFU) ULTRASOUND ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011
  • TABLE 69 MAGNETIC RESONANCE GUIDED ULTRASOUND ABLATORS (MRG-FUS) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 70 MAGNETIC RESONANCE GUIDED ULTRASOUND ABLATORS (MRG-FUS) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011
  • TABLE 71 ULTRASONIC SURGICAL SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 72 ULTRASONIC SURGICAL SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
  • TABLE 73 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 74 MICROWAVE THERMOTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 75 HYDROTHERMAL BALLOON ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 76 HYDROTHERMAL BALLOON ABLATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)
  • TABLE 77 GLOBAL CRYOABLATION MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 78 GLOBAL CRYOABLATION MARKET VOLUME, BY SEGMENTS, 2009 - 2011
  • TABLE 79 GLOBAL CRYOABLATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 80 GLOBAL CRYOABLATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016
  • TABLE 81 TISSUE CONTACT PROBE CATHETER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 82 TISSUE CONTACT PROBE CATHETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011
  • TABLE 83 TISSUE SPRAY PROBE CATHETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 84 TISSUE SPRAY PROBE CATHETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011
  • TABLE 85 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 86 GLOBAL ABLATION DEVICES MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
  • TABLE 87 FREQUENTLY USED THERAPIES FOR CANCER ABLATION
  • TABLE 88 CANCER ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 89 CARDIOVASCULAR ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 90 OPHTHALMOLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 91 GYNECOLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 92 UROLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 93 ORTHOPEDICS ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 94 OTHER APPLICATIONS ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 95 GLOBAL ABLATION TECHNOLOGIES MARKET, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
  • TABLE 96 AMERICAS: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 97 AMERICAS: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 98 AMERICAS: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 99 EUROPE: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 100 EUROPE: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 101 EUROPE: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 102 ASIA - PACIFIC: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 103 ASIA-PACIFIC: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 104 ASIA-PACIFIC: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
  • TABLE 105 ROW: ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
  • TABLE 106 ROW: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
  • TABLE 107 ROW: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)
  • TABLE 108 MERGERS & ACQUISITIONS, JANUARY 2009 - APRIL 2012
  • TABLE 109 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, JANUARY 2009 - APRIL 2012
  • TABLE 110 NEW PRODUCT LAUNCHES, JANUARY 2009 - APRIL 2012
  • TABLE 111 PIPELINE DEVELOPMENTS, JANUARY 2009 - APRIL 2012
  • TABLE 112 OTHER DEVELOPMENTS, JANUARY 2009 - APRIL 2012
  • TABLE 113 ACCURAY INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 114 ACCURAY INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 115 ACCURAY INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 116 ALCON LABORATORIES INC.: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)
  • TABLE 117 ALCON LABORATORIES INC.: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
  • TABLE 118 ANGIODYNAMICS INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 119 ANGIODYNAMICS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 120 ANGIODYNAMICS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 121 ARTHROCARE CORP : TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 122 ARTHROCARE CORP : TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 123 ARTHROCARE CORP : TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 124 ATRICURE INC. : TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 125 ATRICURE INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 126 BOSTON SCIENTIFIC CORP : TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 127 BOSTON SCIENTIFIC CORP : TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 128 BOSTON SCIENTIFIC CORP : TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 129 BSD MEDICAL CORP : TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 130 C.R. BARD INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 131 C.R. BARD INC. : TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 132 C.R. BARD INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 133 CONMED CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 134 CONMED CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 135 CONMED CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 136 COVIDIEN PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 137 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 138 COVIDIEN PLC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 139 ELEKTA AB: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 140 ELEKTA AB : TOTAL REVENUES, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 141 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 142 MEDTRONIC INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 143 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 144 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 145 MISONIX INC. : TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 146 MISONIX INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 147 MISONIX INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 148 OLYMPUS CORP : TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 149 OLYMPUS CORP : TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 150 OLYMPUS CORP : TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 151 SMITH & NEPHEW: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 152 SMITH & NEPHEW: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 153 SMITH & NEPHEW: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 154 ST. JUDE MEDICAL INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 155 ST. JUDE MEDICAL INC: TOTAL REVENUES, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 156 ST. JUDE MEDICAL INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 157 UROLOGIX INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 158 UROLOGIX INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 159 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 160 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 161 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL THERMAL ABLATION TECHNOLOGIES MARKET, 2011 VS. 2016
  • FIGURE 2 GLOBAL NON-THERMAL ABLATION TECHNOLOGIES MARKET, 2011 VS. 2016
  • FIGURE 3 GRAPHICAL RANKING OF TOTAL ABLATION MARKET
  • FIGURE 4 ABLATION TECHNOLOGIES MARKET SEGMENTATION
  • FIGURE 5 MARKET SEGMENTATION OF ABLATION TECHNOLOGIES, BY APPLICATION
  • FIGURE 6 MARKET DYNAMICS
  • FIGURE 7 MARKET SHARE ANALYSIS, BY PLAYERS, 2011
  • FIGURE 8 MARKET SHARE OF ABLATION DEVICES MARKET, BY CLINICAL APPLICATION, IN 2011
  • FIGURE 9 STRATEGIES EMPLOYED BY MARKET PLAYERS IN CANCER ABLATION MARKET, JANUARY 2000 - MARCH 2012
  • FIGURE 10 TECHNOLOGIES FOCUSED BY MARKET PLAYERS FOR LAUNCHED PRODUCTS, JANURAY 2000 - MARCH 2012
  • FIGURE 11 TECHNOLOGIES FOCUSED BY MARKET PLAYERS FOR PRODUCTS IN PIPELINE, JANUARY 2009 - MARCH 2012
  • FIGURE 12 SHARE OF VARIOUS CARDIAC ABLATION PROCEDURES, 2011
  • FIGURE 13 STRATEGIES EMPLOYED BY THE MARKET PLAYERS IN THE CARDIAC ABLATION FIELD, JANUARY 2000 - MARCH 2012
  • FIGURE 14 MARKET SHARE OF ABLATION DEVICES, BY GEOGRAPHY, 2011
  • FIGURE 15 KEY GROWTH STRATEGIES, JANUARY 2000 - MARCH 2012
  • FIGURE 16 KEY PLAYERS FOCUSING ON MERGER & ACQUISITION STRATEGY, JANUARY 2000 - MARCH 2012
  • FIGURE 17 KEY PLAYERS FOCUSING ON PARTNERSHIPS & ALLIANCES STRATEGY, JANUARY 2000 - MARCH 2012
  • FIGURE 18 KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCH STRATEGY, JANUARY 2000 - MARCH 2012
  • FIGURE 19 KEY PLAYERS FOCUSING ON PRODUCTS IN PIPELINE, JANUARY 2009 - MARCH 2012
Back to Top